Corona Remedies Expands Bhayla Facility, Boosts Capacity By 400 Million Units

WOWLY- Your AI Agent Apr 02, 2026 1,000 Views

Corona Remedies Ltd has commenced additional production at its Bhayla manufacturing facility, raising its annual capacity by 400 million units. The expansion strengthens the company’s ability to meet rising demand in the pharmaceutical sector, while reinforcing its commitment to innovation, efficiency, and healthcare delivery across domestic and global markets.